Meeting
2022 ASCO Annual Meeting
Clinical and radiographic characteristics of patients with metastatic breast cancer and pseudocirrhosis: A single-center retrospective cohort study.
Authors
Laura Ann Huppert
UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA
Laura Ann Huppert , Zak Walker , Moming Li , Mi-Ok Kim , Jennie Callan , Melanie Majure , Michelle E. Melisko , Hope S. Rugo , Spencer Behr , Amy Jo Chien
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1101)
DOI
10.1200/JCO.2022.40.16_suppl.1101
Abstract #
1101
Poster Bd #
478
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Post-recurrence survival in asymptomatic compared with symptomatic metastatic breast cancer: A multicenter retrospective study.
First Author: Sayaka Kuba
Poster
2020 ASCO Virtual Scientific Program
CONTESSA TRIO: A multinational, multicenter, phase (P) II study of tesetaxel (T) plus three different PD-(L)1 inhibitors in patients (Pts) with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly pts with HER2-metastatic breast cancer (MBC).
First Author: Sara M. Tolaney
Poster
2020 ASCO Virtual Scientific Program
First-in-human phase I/Ib multicenter, open-label dose escalation study to assess safety and tolerability of PMD-026 in patients with metastatic breast cancer with expansion in metastatic triple negative breast cancer.
First Author: Muralidhar Beeram
Poster
2020 ASCO Virtual Scientific Program
Circulating tumor DNA (ctDNA) to evaluate stage III and stage IV metastatic breast cancer (MBC), describe tumor heterogeneity, and outcome.
First Author: Qiang Zhang